Ms. Najla Guthrie
Ms. Najla Guthrie, President/CEO is an internationally recognized scientist in the field of nutrition and breast cancer. Her original research, conducted at the Centre for Human Nutrition of the University of Western Ontario, focused on the anti-cancer effects of minor food components, flavonoids, limonoids and tocotrienols, in cell culture, animal models and clinical trials. Ms. Guthrie has published over 32 papers in peer-reviewed journals and has given numerous invited presentations at national and international scientific and industry events. Her research, which has demonstrated the anti-cancer properties of citrus juices and their constituent flavonoids, continues to generate a tremendous amount of scientific and media interest. A founding shareholder, Ms. Guthrie has successfully transitioned from a nutraceutical medicines researcher to CEO of KGK. The Company has under her leadership established, and executed on, a strategic plan to leverage its research infrastructure and generate sufficient capital to finance the development of new and patented nutraceutical product groups of its own. Ms. Guthrie has led and managed the Company's profitable growth of its contract research business over the past twelve years; and has been responsible for recruitment of an integrated research and product development team that today maintains a reputation for world-class nutraceutical science. Ms. Guthrie is responsible for the strategic development of the patenting process, marketing and sales strategies and business development. She is also responsible for the commercialization and licensing of KGK's cholesterol reduction product currently being marketed. In addition, Ms. Guthrie is widely recognized as a leading nutraceutical industry expert and spokesperson; as well as being active in several nutraceutical industry groups.
Malkanthi Evans, D.V.M., M.Sc., Ph.D.
Dr. Mal Evans is the scientific director at KGK Science. She earned her master's and doctorate degrees in physiology from the University of Guelph and received her D.V.M with distinction in physiology from the University of Sri Lanka. Dr. Evans pioneered research in chronobiology and her landmark work in this area was the first of its kind in North America to focus on the impact of hormone rhythms as messenger systems and their impact on organ systems and physiology. As KGK's scientific director, Dr. Evans contributes her specialized knowledge to dietary supplement research, study design, and the development of clinical trial protocols for claims substantiation, as well as authoring final reports and manuscripts for publication. She brings her experience and knowledge in Evidence-Based Medicine into the area of Evidence-Based Nutrition for application to the Dietary Supplement Industry. Her expertise encompasses research in numerous areas including weight loss/management, gut health/microbiome, cardiovascular health, cognition, menopause, hypertension, arthritis, digestive health, eye health, IBS, vitamin research, women's and men's health, oxidative stress, immune function, allergies, satiety, dermatology, bioavailability, and various disease pre-disease indications. Dr. Evans has authored more than 35 peer-reviewed publications and over 100 protocols and clinical study reports for presentation to Health Canada, FDA and/or EFSA for claims substantiation. She has presented abstracts at prestigious international scientific meetings and contributed to numerous respected international industry publications. Dr. Evans is a frequent speaker at conferences on clinical trial design and the need for a new paradigm in study design and in identifying biomarkers for the dietary supplement industry.
Andrew Charrette, MS
Enthusiastic about the application of science, Andrew Charrette, ardently strives to impassion the people around him with dedication to quality research. Andrew received his undergraduate degree in Pharmacology and Physiology from the University of Western Ontario. After gaining technical skills as a healthcare information analyst, he obtained a Masters degree in Neuroscience from the University of Ottawa. Andrew later bolstered his knowledge of microbiology and pharmacology through working as a medical writer. Prior to his current role, Andrew gleaned experience in the dietary supplement industry through managing regulatory affairs at KGK.